Prescription drug dependency is clinical addiction to medications that were — at least initially — taken under medical direction or purchased for a legitimate symptom. In India, the pattern runs across four main drug categories, affects a wide demographic, and is substantially under-recognised by the families it affects because the substances arrived through a pharmacy, not a dealer.
For families, this matters for a specific reason: the signs of prescription dependency are often missed because everyone assumes "the doctor prescribed it, so it must be fine." That assumption is wrong in a large and growing number of cases.
Why prescription dependency is different
Three features distinguish prescription addiction from street drug addiction, and each has implications for how families respond.
First, the substances are legal when prescribed, which means the person is not hiding a criminal activity. They are simply taking their medicine. Family members often do not know dependency is developing until it is well-established.
Second, dependency often starts from a real medical need. A genuine injury, genuine anxiety, genuine pain. The slide from treatment to dependency is gradual and does not feel like the classic addiction narrative.
Third, withdrawal from several prescription drug classes — particularly benzodiazepines — is medically dangerous. Sudden cessation can produce seizures. This rules out several of the informal strategies that families try first.
The four categories that matter in India
Opioid painkillers — tramadol, codeine, tapentadol
Tramadol is the dominant prescription opioid in Indian dependency cases. Originally positioned as a weaker, safer opioid, it has been widely over-prescribed and is now one of the most-seen substances in addiction medicine practice. Codeine is usually consumed as a cough syrup (codeine-based formulations are still widely available despite restrictions) and has its own subculture of dependency. Tapentadol is a newer entrant showing the same pattern.
Benzodiazepines — alprazolam (Alprax, Xanax), clonazepam, lorazepam, diazepam
Prescribed for anxiety, insomnia, or panic. Tolerance develops within weeks, and dependency within months. Patients escalate dose to achieve the same effect, source from multiple doctors or pharmacies, and experience significant withdrawal on any attempt to stop. Benzodiazepine dependency is particularly common among middle-aged urban women who began using them for sleep years earlier.
Gabapentinoids — pregabalin (Lyrica), gabapentin
Prescribed for nerve pain, anxiety, and fibromyalgia. Misuse has grown substantially in the last decade — particularly as a supplement to other substances. Produces calming and euphoric effects at higher doses. Withdrawal produces severe anxiety, insomnia, and rebound pain.
Stimulants — methylphenidate (Ritalin, Concerta), modafinil
Less common than the first three but growing — particularly among students and working professionals seeking cognitive enhancement. Dependency is psychological more than physical, but the pattern is clinically recognisable.
How dependency typically develops
A representative case: a thirty-eight-year-old executive develops chronic back pain after a minor accident. His doctor prescribes tramadol for two weeks. The pain improves but has not resolved at the end of the course, and he asks for a refill. Over the next year, he obtains tramadol from three different doctors, then from a pharmacy that does not ask for fresh prescriptions. His dose has risen from 50mg twice daily to 100mg four times daily. He has started feeling anxious and restless if he misses a dose. The "back pain" he is now treating is, clinically, tramadol withdrawal. His family thinks he is on a long-term pain medication. He himself is not fully aware of what has happened.
Variations of this story — with different drugs, different symptoms, different durations — make up a substantial fraction of our admissions. The common thread is that nobody made a decision to become dependent. The dependency developed through a series of reasonable-looking small decisions, each of which made sense in isolation.
Why stopping suddenly is dangerous
This is the single most important point in this article. Stopping benzodiazepines abruptly can produce seizures that are potentially fatal. Stopping high-dose opioids abruptly produces severe withdrawal. Stopping gabapentinoids abruptly produces severe anxiety and sleep disruption. In all cases, supervised tapering is required.
This is non-negotiable. Benzodiazepine withdrawal can produce seizures and, in severe cases, be fatal. If the person in your family is on regular alprazolam, clonazepam, or lorazepam and is contemplating stopping, that conversation should happen with a psychiatrist, not at the kitchen table.
The common family mistake — "I'll just throw away his pills and make him tough it out" — is dangerous with prescription drug dependency. It is the one scenario where cold turkey is not just hard but medically contraindicated.
The treatment pathway
At SimranShri, prescription drug dependency is treated on the same residential framework as other substance dependencies, with specific medical adjustments.
- Days 1-3: Full medical assessment. Exact drug, dose, frequency, and duration of use are documented. Toxicology confirms the profile. Psychiatric evaluation identifies any underlying condition (e.g. anxiety disorder) that the medication was originally prescribed for.
- Days 3-14: Medically supervised taper. The rate of taper depends on the drug class — benzodiazepines may taper over weeks, opioids faster, gabapentinoids more gradually. Withdrawal symptoms are managed with supportive medication.
- Weeks 3-10: Intensive therapy phase. CBT for dependency-related patterns, work on the original condition the medication was addressing, family sessions, trigger mapping.
- Weeks 10+: Discharge planning with specific attention to the original medical condition. Handover to a psychiatrist or physician who can manage the underlying condition without re-introducing dependency-forming medications.
- Aftercare: Twelve-month structured programme including medication monitoring, outpatient counselling, and family sessions.
A specific feature of prescription drug treatment is that the original medical condition often still needs treatment. A person dependent on alprazolam for anxiety is not anxiety-free once off alprazolam. The anxiety needs to be addressed — with non-dependency-forming medication where appropriate, with therapy, with lifestyle intervention. This is why discharge handover to a psychiatrist or physician matters so much in this population.
The first step is an assessment, not confrontation. Bring the medications, the prescriptions if available, and your own observations. Our admissions team will walk you through whether what you are describing is clinical dependency and what treatment would look like. First call is confidential.
- Prescription drug dependency is substantially under-recognised in Indian families because everyone assumes "the doctor prescribed it" means it is fine. Often it is not.
- The four categories that matter: opioid painkillers (tramadol, codeine, tapentadol), benzodiazepines (alprazolam, clonazepam, lorazepam), gabapentinoids (pregabalin, gabapentin), and stimulants (methylphenidate, modafinil).
- Benzodiazepine withdrawal can be medically dangerous and can produce seizures. Stopping suddenly without supervision is contraindicated.
- Dependency typically develops from a real medical need through a series of small, reasonable-looking decisions — not through recreational misuse.
- Treatment combines medically supervised taper with therapy and requires a handover plan for the original medical condition the medication was treating.
- If your family member is on benzodiazepines and wants to stop, that conversation should happen with a psychiatrist, not at the kitchen table.
